Entries tagged "GlaxoSmithKline"
Acquisitive GlaxoSmithKline already snapped up South Africa's Aspen Pharmacare Holdings and Stiefel Laboratories in the last month, and now India's Shanta may be next.
When Carl Icahn gets involved in biotech companies, action often follows. He sold off ImClone Systems Inc. to Eli Lilly and Co., helped split Enzon Pharmaceuticals in two and unsuccessfully pushed for a sale of Biogen Idec Inc. ...
GlaxoSmithKline plc agreed Monday to pay Actelion Ltd. as much as Sfr2.735 billion ($2.74 billion) including milestone fees for the rights to develop and market the Swiss biotechnology firm's experimental sleep disorder drug almorexant. ...
Here's a preview of all of the dealmaking events you need to know about for the week of May 19th. The HSR Act expires for British drug company GlaxoSmithKline's $720 million purchase of Sirtis Pharmaceuticals; Draxis Health shareholders will vote on the proposed merger with drug maker Jubilant; and retailers Target, Home Depot, Limited Brands, Gap, and Talbots will report and discuss earnings. Suzanne Stevens, senior editor of Corporate Dealmaker, joins us this week with a closer look at Talbots' earnings. - The editors...
Drug giant GlaxoSmithKline plc will buy clinical-stage biotech Sirtris Pharmaceuticals Inc. for $720 million. GlaxoSmithKline plc's legal counsel include Victor Lewkow, Arthur Kohn and Lillian Raben of Cleary Gottlieb Steen & Hamilton LLP. Sirtris turned to investment bankers Douglas Braunstein and Robbie Huffines of J.P. Morgan & Chase Co. For legal advice Sitris used Marc Rubenstein and Jonathan Grandon of Ropes & Gray LLP. ...
